PROM1 and cancer: Primary CR-CSC lines, characterized for CD133 18 expression and high Wnt/β-catenin pathway activity 6, and SDACs from distinct human CR cancer specimens derived from seven patients (stage II-IV) undergoing CR resection (see Supporting Information) were analyzed by Raman spectroscopy.